Related Experiment Video
Updated: Jun 14, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF?
Jane Cochrane Caldwell1, Mamas A Mamas, Ludwig Neyses
1University of Manchester, Manchester Heart Centre, Manchester Royal Infirmary, Oxford Rd, Manchester, UK. jane.caldwell@manchester.ac.uk
Background:
Heart failure (HF) and atrial fibrillation (AF) are common disorders that frequently occur together and are associated with an increased risk of thromboembolism. This thromboembolic risk may be reduced by anticoagulation with warfarin but not without introducing new hemorrhagic risks.
Methods And Results:
Current guidelines recommend the use of anticoagulation in patients with HF and chronic AF and paroxysmal AF (PAF) that is symptomatic or frequent and prolonged enough to be detected by electrocardiogram. However, the evidence supporting these recommendations is weak and does not take account of research indicating that the prothrombotic risk is higher in more severe HF.
Conclusions:
An area not addressed by current guidelines is anticoagulation in patients with HF and short, asymptomatic episodes of AF. These issues need to be resolved with further studies using implanted devices to detect such asymptomatic PAF.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure IV: Classification and Diagnostic Evaluation

